1st Quarter - Amendment

MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY for MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY

Firm
Client
Income
—
Expenses
$1,220,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report Apr 21, 2025 $1,220,000 Replaced
1st Quarter - Amendment (this page) Apr 24, 2025 $1,220,000 Yes

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Equitable Community Access to Pharmacist Services Act; H.R. 4011 Timely Access to Cancer Treatment; Medically integrated physician dispensing regulations; S.127, PBM Transparency Act; Drug price transparency and cost savings opportunities.

LobbyistCovered position, as disclosed
JOSHUA C BABB —
BRIAN BRANTON New Chief of Staff, Congressman Polis; Chief of Staff, Congressman Sestak; Legislative Director, Congressman Wu; Legislative Counsel, Congressman Holt; Legislative Assistant, Congresswoman Mink
RICHARD BUCKLEY —
JASEY CARDENAS —
DIANA FELNER New —
BEN JONES —
MATTHEW WILLIAMS —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Bills named: H.R. 4011 (119th), S. 127 (119th)

Taxation/Internal Revenue Code TAX

Last-in, first-out (LIFO) Inventory Accounting Method; H.R.5376 The Inflation Reduction Act

LobbyistCovered position, as disclosed
JASEY CARDENAS —
BEN JONES —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5376 (119th)

Health Issues HCR

Equitable Community Access to Pharmacist Services Act; Clinical trial diversity, health equity; Emergency preparedness and response. PAHPA Reauthorization; Healthcare innovation, ARPA-H, oncology research; Community Health Center Reauthorization; Benefit cost and transparency, real time benefit tools and patient APIs - S. 1339; Controlled Substance Reporting; Pharmaceutical Manufacturing and Supply Chain Shortage; Alleviating Drug Shortages; Telehealth Modernization Act of 2024; H.R.4011 Timely Access to Cancer Treatment Act; H.R.2630, S.652 The Safe Step Act; H.R. 2474, Strengthening Medicare for Patients and Providers Act; H.R. 3561, PATIENT Act; H.R. 4473, Medicare Patient Access to Cancer Treatment Act; HR 2484 Seniors Access to Critical Medications Act; H.R.5376 The Inflation Reduction Act.

LobbyistCovered position, as disclosed
JOSHUA C BABB —
BRIAN BRANTON New Chief of Staff, Congressman Polis; Chief of Staff, Congressman Sestak; Legislative Director, Congressman Wu; Legislative Counsel, Congressman Holt; Legislative Assistant, Congresswoman Mink
RICHARD BUCKLEY —
JASEY CARDENAS —
DIANA FELNER New —
BEN JONES —
MATTHEW WILLIAMS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 652 (119th), H.R. 2630 (119th), H.R. 2484 (119th), H.R. 2474 (119th), H.R. 3561 (119th), S. 1339 (119th), H.R. 4011 (119th), H.R. 4473 (119th), H.R. 5376 (119th)

Medicare/Medicaid MMM

Equitable Community Access to Pharmacist Services Act; Healthcare innovation and oncology research; H.R.3173, S.3018 The Improving Seniors Timely Access to Care Act; Medically integrated physician dispensing regulations; HR 2484 Seniors Access to Critical Medications Act

LobbyistCovered position, as disclosed
JOSHUA C BABB —
BRIAN BRANTON New Chief of Staff, Congressman Polis; Chief of Staff, Congressman Sestak; Legislative Director, Congressman Wu; Legislative Counsel, Congressman Holt; Legislative Assistant, Congresswoman Mink
RICHARD BUCKLEY —
JASEY CARDENAS —
DIANA FELNER New —
BEN JONES —
MATTHEW WILLIAMS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 2484 (119th), H.R. 3173 (119th), S. 3018 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.